Hi all, serious question. This report gives an unbiased view of ORN, it's upside / projects and then goes into great detail the share PRICE and potential upside based on returns etc. Given the above, how is the report considered not to be price sensitive?
- Forums
- ASX - By Stock
- ORN
- Ann: Hannam & Partners Issue Research Report
Ann: Hannam & Partners Issue Research Report, page-2
Featured News
Add ORN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $116.2M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $458 | 27.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1499991 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 516950 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1499991 | 0.016 |
2 | 322502 | 0.015 |
1 | 1500000 | 0.014 |
2 | 276920 | 0.013 |
2 | 133330 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 516950 | 3 |
0.019 | 233427 | 2 |
0.020 | 1339722 | 5 |
0.021 | 620000 | 2 |
0.022 | 550645 | 2 |
Last trade - 15.32pm 15/11/2024 (20 minute delay) ? |
Featured News
ORN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online